Your Messages Inbox
Your Article Summary
See Latest ArticlesKing Pharmaceuticals Reports Second Quarter 2009 Financial Results
King Pharmaceuticals, 08/07/09
King Pharmaceuticals, Inc. announced that total revenues were $445 million during the second quarter ended June 2009, compared to $397 million in the second quarter of 2008. The Company reported a net income of $38 million and diluted earnings per share of $0.15 during the second quarter of 2009, compared to net income of $41 million and diluted earnings per share of $0.17 in the second quarter of the prior year. Excluding certain special items and recurring non–GAAP adjustments, adjusted net income equaled $80 million and adjusted diluted earnings per share equaled $0.32 during the second quarter ended June 2009, compared to adjusted net income of $87 million and adjusted diluted earnings per share of $0.35 in the second quarter of 2008.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
Medtronic Board Approves Third Quarter Cash Dividend for Fiscal Year 2010
Medtronic, 12/04/09
Taro Provides Preliminary Third Quarter and Year-to-Date 2009 Financial Results
Taro Pharmaceuticals USA, 12/03/09
IMS Predicts 4% to 6% Global Pharma Market Growth Next Year
U.S. Pharmacist, 12/02/09
Article Search
Sponsor